Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress

Experimental Biology and Medicine

Volumn 234, Issue 7, 2009, Pages 785-793

  Dang, Haixia ^a   Sun, Lihua ^a   Liu, Xinmin ^a   Peng, Bo ^a   Wang, Qiong ^a   Jia, William ^b   Chen, Ying ^a   Pan, Aihua ^c   Xiao, Peigen ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Sinobioway Group Co Ltd   (China)

Author keywords

Chronic mild stress; Cognitive impairment; Depression; Kai Xin San

Indexed keywords

ACETYLCHOLINESTERASE; CORTICOSTERONE; CORTICOTROPIN; HERBACEOUS AGENT; KAI XIN SAN EXTRACT; MONOAMINE; SUCROSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHOLINERGIC SYSTEM; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DEPRESSION; DISEASE MODEL; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; FEEDING; FEMALE; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LATENT PERIOD; MALE; NEUROCHEMISTRY; NONHUMAN; PASSIVE AVOIDANCE; PASSIVE MOVEMENT; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; STRESS; SYMPTOM; TASK PERFORMANCE; UPREGULATION;

ACETYLCHOLINESTERASE; ACORUS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CHRONIC DISEASE; COGNITION DISORDERS; CORTICOSTERONE; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; MALE; NOREPINEPHRINE; PANAX; POLYGALA; PORIA; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 67650251674     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0812-RM-354     Document Type: Article

References (44)

1. Sergeyev V, Fetissov S, Mathé AA, Jimenez PA, Bartfai T, Mortas P, Gaudet L, Moreau JL, Hökfelt T. Neuropeptide expression in rats exposed to chronic mild stresses. Psychopharmacology 178:115-124, 2005.
2. Austin MP, Mitchell P, Goodwin GM. Cognitive deficits in depression, possible implications for functional neuropathology. Br J Psychiatry 178:200-206, 2001.
3. Porter RJ, Gallacher P, Thompson JM, Young AH. Neurocognitive impairment in drug-free patients with major depressive disorder. Am J Psychiatry 182:214-220, 2003.
4. Kennedy SH. A review of antidepressant treatments today. Eur Neuropsychopharmacol 16:5619-5624, 2006.
5. Monleón S, Vinader-Caerols C, Arenas MC, Parra A. Antidepressant drugs and memory: insights from animal studies. Eur Neuropsychopharmacol 18:235-248, 2008.
6. Chen YH, Wang DX, Liu P, Wang JL, Dai C, Cheng GF. Antidepression effect of Kai Xin San and research of its compatibility. Chin Med J 118:1214-1216, 2005.
7. Nishiyama N, Zhou Y, Saito H. Beneficial effects of DX-9386, a traditional Chinese prescription, on memory disorder produced by lesioning the amygdala in mice. Biol Pharm Bull 17:1679-1681, 1994a.
8. Nishiyama N, Zhou Y, Saito H. Ameliorative effects of chronic treatment using DX-9386, a traditional Chinese prescription, on learning performance and lipid peroxide content in senescence accelerated mouse. Biol Pharm Bull 17:1481-1484, 1994b.
9. Nishiyama N, Zhou Y, Takashina K, Saito H. Effects of DX-9386, a traditional Chinese preparation, on passive and active avoidance performances in mice. Biol Pharm Bull 17:1472-1476, 1994c.
10. Zhang Y, Saito H, Nishiyama N, Abe K. Effects of DX-9386, a traditional Chinese medicinal prescription, on long-term potentiation in the dentate gyrus in rats. Biol Pharm Bull 17:1337-1340, 1994a.
11. Smriga M, Saito H, Nishiyama N. Hoelen (Poria Cocos Wolf) and ginseng (Panax Ginseng C. A. Meyer), the ingredients of a Chinese prescription DX-9386, individually promote hippocampal long-term potentiation in vivo. Biol Pharm Bull 18:518-522, 1995.
12. Zhang Y, Saito H, Nishiyama N. Improving effects of DX-9386, a traditional Chinese medicinal prescription, on thymectomy-induced impairment of learning behaviors in mice. Biol Pharm Bull 17:1199-2205, 1994b.
13. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93:358-364, 1987.
14. Song L, Che W, Min-Wei W, Murakami Y, Matsumoto K. Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacol Biochem Behav 83:186-193, 2006.
15. Millan MJ. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110:135-370, 2006.
16. American Psychiatric Association. DSM IV-Diagnostic and Statistical Manual of Psychiatric Disorders (4th ed.). Washington, DC: American Psychiatric Association, 1994.
17. Dulawa SC, Hen R. Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 29:771-783, 2005.
18. Katz RJ. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol Biochem Behav 16:965-968, 1982.
19. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic model of depression. Neurosci Biobehav Rev 16:525-534, 1992.
20. Muscat R, Papp M, Willner P. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology 109:433-438, 1992.
21. Stepanichev MY, Kudryashova IV, Yakovlev AA, Onufriev MV, Khaspekov LG, Lyzhin AA, Lazareva NA, Gulyaeva NV. Central administration of a caspase inhibitor impairs shuttle-box performance in rats. Neuroscience 136:579-591, 2005.
22. Elhwuegi AS. Central monoamine and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 28:435-451, 2004.
23. Charney DS. Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry 59:11-14, 1998.
24. Lambert G, Johansson M, Agren H, Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness. Arch Gen Psychiatry 57:787-793, 2000.
25. Konstandi M, Johnson E, Lang MA, Malamas M, Marselos M. Noradrenaline, dopamine, serotonin: different effects of psychological stress on brain biogenic amines in mice and rats. Pharmacol Res 41:341-346, 2000.
26. Bekris S, Antonious K, Daskas S, Papadopoulous-Daifoti Z. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res 161:45-59, 2005.
27. Heninger GR, Charney DS, Sternberg DE. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiatry 41:398-402, 1984.
28. Naughton M, Mulrooney JB, Leonard BE. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol 15:397-415, 2000.
29. Jans L, Riedel WJ, Markus CR, Blokland A. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12:522-543, 2007.
30. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160:1-12, 1999.
31. Blokland A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res Brain Res Rev 21:285-300, 1995.
32. Christensen H, Griffiths K, Mackinson A, Jacomb P. A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. J Int Neuropsychol Soc 3:631-651, 1997.
33. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychol 48:813-829, 2000.
34. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 11:240-249, 2001.
35. Fossati P, Ergis AM, Allilaire JF. Problem-solving abilities in unipolar depressed patients: comparison of performance on the modified version of the Wisconsin and the California sorting tests. Psychiatry Res 104:145-156, 2001.
36. Alexopoulos GS, Kiosses DN, Heo M, Murphy CF, Shanmugham B, Gunning-Dixon F. Executive dysfunction and the course of geriatric depression. Biol Psychiatry 58:204-210, 2005.
37. Chen KC, Baxter MG, Rodefer JS. Central blockade of muscarinic cholinergic receptors disrupts affective and attentional setshifting. Eur J Neurosci 20:1081-1088, 2004.
38. Manikandan S, Padma MK, Srikumar R, Jeva. Parthasarathv N, Muthuvel A, Sheela Devi R. Effects of chronic noise stress on spatial memory of rats in relation to neuronal dendritic alteration and free radical-imbalance in hippocampus and medial prefrontal cortex. Neurosci Lett 399:17-22, 2006.
39. Yamaguchi Y, Kawashima S. Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat. Eur J Pharmacol 412:265-272, 2001.
40. Li C, Yang J, Yu S, Chen N, Xue W, Hu J, Zhang D. Triterpenoid saponins with neuroprotective effects from the roots of Polygala tenuifolia. Planta Med 72:133-141, 2008.
41. Kawashima K, Miyako D, Ishino Y, Makino T, Saito K, Kano Y. Anti-stress effects of 3,4,5-trimethoxycinnamic acid, an active constituent of roots of Polygala tenuifolia. Biol Pharm Bull 27:1317-1319, 2004.
42. Chen YL, Hsien CL, Wu PH, Lin JG. Effect of Polygala tenuifolia root on behavioral disorders by lesioning nucleus basalis magnocellularis in rat. J Ethnopharmacol 95:47-55, 2004.
43. Koo BS, Park KS, Ha JH, Park JH, Lim JC, Lee DU. Inhibitory effects of the fragrance inhalation of essential oil from Acorus gramineus on central nervous system. Biol Pharm Bull 26:978-982, 2003.
44. Roca CA, Schmidt PJ, Danaceau MA, Altemus M, Putnam K, Chrousos GP, Nieman LK, Rubinow DR. Sex-related differences in stimulated hypothalamic-pituitary-adrenal axis during induced gonadal suppression. J Clin Endocrinol Metab 90:4224-4231, 2005.